Changing trends in well differentiated thyroid carcinoma over eight decades

International Journal of Surgery

Volumn 10, Issue 10, 2012, Pages 618-623

  Nixon, Iain J ^a   Ganly, Ian ^a   Patel, Snehal G ^a   Palmer, Frank L ^a   Whitcher, Monica M ^a   Ghossein, Rony ^a   Michael Tuttle, R ^a   Shaha, Ashok R ^a   Shah, Jatin P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Follicular thyroid cancer; Hurthle cell thyroid cancer; Papillary thyroid cancer; Thyroid; Well differentiated

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84870751903     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2012.10.005     Document Type: Article

References (31)

1. Chen A.Y., Jemal A., Ward E.M. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009, 115(16):3801-3807. Epub 2009/07/15.
2. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006, 295(18):2164-2167. Epub 2006/05/11.
3. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009, 18(3):784-791. Epub 2009/02/26.
4. Elaraj D.M., Sturgeon C. Adequate surgery for papillary thyroid cancer. Surgeon 2009, 7(5):286-289. Epub 2009/10/24.
5. Mitchell I., Livingston E.H., Chang A.Y., Holt S., Snyder W.H., Lingvay I., et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 2007, 142(6):823-828. discussion 8 e1. Epub 2007/12/08.
6. Shaha A.R. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004, 114(3):393-402. Epub 2004/04/20.
7. Hay I.D., Hutchinson M.E., Gonzalez-Losada T., McIver B., Reinalda M.E., Grant C.S., et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 2008, 144(6):980-987. discussion 7-8. Epub 2008/12/02.
8. Mazzaferri E.L. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr Pract 2000, 6(6):469-476. Epub 2001/01/13.
9. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214. Epub 2009/10/29.
10. Pacini F., Schlumberger M., Dralle H., Elisei R., Smit J.W., Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006, 154(6):787-803. Epub 2006/05/27.
11. Watkinson J.C. The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun 2004, 25(9):897-900. Epub 2004/08/21.
12. Shaha A.R., Shah J.P., Loree T.R. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck 1998, 20(1):26-30. Epub 1998/02/17.
13. Shaha A.R., Loree T.R., Shah J.P. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995, 118(6):1131-1136. discussion 6-8. Epub 1995/12/01.
14. Shaha A.R., Shah J.P., Loree T.R. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996, 3(6):534-538. Epub 1996/11/01.
15. Hay I.D., Thompson G.B., Grant C.S., Bergstralh E.J., Dvorak C.E., Gorman C.A., et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002, 26(8):879-885. Epub 2002/05/23.
16. Sanders L.E., Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998, 133(4):419-425. Epub 1998/05/23.
17. Hughes D.T., Haymart M.R., Miller B.S., Gauger P.G., Doherty G.M. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 2011, 21(3):231-236. Epub 2011/01/28.
18. Morris L.G., Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010, 200(4):454-461. Epub 2010/06/22.
19. Tollefsen H.R., Decosse J.J., Hutter R.V. Papillary carcinoma of the thyroid. A clinical and pathological study of 70 fatal cases. Cancer 1964, 17:1035-1044. Epub 1964/08/01.
20. Cody H.S., Shah J.P. Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan-Kettering Cancer Center. Am J Surg 1981, 142(4):480-483. Epub 1981/10/01.
21. McConahey W.M., Hay I.D., Woolner L.B., van Heerden J.A., Taylor W.F. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986, 61(12):978-996. Epub 1986/12/01.
22. Nixon I.J., Ganly I., Patel S.G., Palmer F.L., Whitcher M.M., Tuttle R.M., et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 2011, Epub 2011/10/18.
23. Shah J.P., Loree T.R., Dharker D., Strong E.W. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 1993, 166(4):331-335. Epub 1993/10/01.
24. Hassanain M., Wexler M. Conservative management of well-differentiated thyroid cancer. Can J Surg 2010, 53(2):109-118. Epub 2010/03/26.
25. Barney B.M., Hitchcock Y.J., Sharma P., Shrieve D.C., Tward J.D. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck 2011, 33(5):645-649. Epub 2010/08/06.
26. Bilimoria K.Y., Bentrem D.J., Ko C.Y., Stewart A.K., Winchester D.P., Talamonti M.S., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007, 246(3):375-381. discussion 81-4. Epub 2007/08/25.
27. Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988, 104(6):947-953. Epub 1988/12/01.
28. Mazzaferri E.L. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 1997, 7(2):265-271. Epub 1997/04/01.
29. Carcangiu M.L., Zampi G., Rosai J. Poorly differentiated (" insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol 1984, 8(9):655-668. Epub 1984/09/01.
30. Shah J.P., Loree T.R., Dharker D., Strong E.W., Begg C., Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992, 164(6):658-661. Epub 1992/12/01.
31. Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., Grant C.S. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993, 114(6):1050-1057. discussion 7-8. Epub 1993/12/01.